183 related articles for article (PubMed ID: 2970980)
1. Undersulfation of glomerular basement membrane heparan sulfate in experimental diabetes and lack of correction with aldose reductase inhibition.
Cohen MP; Klepser H; Wu VY
Diabetes; 1988 Oct; 37(10):1324-7. PubMed ID: 2970980
[TBL] [Abstract][Full Text] [Related]
2. Aldose reductase inhibition by ponalrestat (statil) does not prevent proteinuria in long-term diabetic rats.
Reddi AS; Jyothirmayi GN
J Diabetes Complications; 1993; 7(4):233-40. PubMed ID: 8219366
[TBL] [Abstract][Full Text] [Related]
3. Release of glomerular heparan-35SO4 proteoglycan by heparin from glomeruli of streptozocin-induced diabetic rats.
Klein DJ; Oegema TR; Brown DM
Diabetes; 1989 Jan; 38(1):130-9. PubMed ID: 2521210
[TBL] [Abstract][Full Text] [Related]
4. Retention of glomerular basement membrane-proteoglycans accompanying loss of anionic site staining in experimental diabetes.
Templeton DM
Lab Invest; 1989 Aug; 61(2):202-11. PubMed ID: 2755078
[TBL] [Abstract][Full Text] [Related]
5. Glomerular proteoglycans in diabetes. Partial structural characterization and metabolism of de novo synthesized heparan-35SO4 and dermatan-35SO4 proteoglycans in streptozocin-induced diabetic rats.
Klein DJ; Brown DM; Oegema TR
Diabetes; 1986 Oct; 35(10):1130-42. PubMed ID: 2944782
[TBL] [Abstract][Full Text] [Related]
6. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
Beyer-Mears A; Ku L; Cohen MP
Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
[TBL] [Abstract][Full Text] [Related]
7. Glomerular basement membrane heparan sulfate glycosaminoglycan in aminonucleoside of puromycin nephrosis.
Garin EH; Shirey AJ
Child Nephrol Urol; 1988-1989; 9(3):121-6. PubMed ID: 2978121
[TBL] [Abstract][Full Text] [Related]
8. Disturbances in glomerular basement membrane glycosaminoglycans in experimental diabetes.
Wu VY; Wilson B; Cohen MP
Diabetes; 1987 Jun; 36(6):679-83. PubMed ID: 3569668
[TBL] [Abstract][Full Text] [Related]
9. [(35)S]sulfate incorporation into glomerular basement membrane glycosaminoglycans is decreased in experimental diabetes.
Cohen MP; Surma ML
J Lab Clin Med; 1981 Nov; 98(5):715-22. PubMed ID: 7028893
[TBL] [Abstract][Full Text] [Related]
10. Glomerular Na+-K+-ATPase activity in acute and chronic diabetes and with aldose reductase inhibition.
Cohen MP; Klepser H
Diabetes; 1988 May; 37(5):558-62. PubMed ID: 2834250
[TBL] [Abstract][Full Text] [Related]
11. Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy.
van den Born J; van Kraats AA; Bakker MA; Assmann KJ; Dijkman HB; van der Laak JA; Berden JH
Diabetologia; 1995 Oct; 38(10):1169-75. PubMed ID: 8690168
[TBL] [Abstract][Full Text] [Related]
12. Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat.
Craven PA; DeRubertis FR
Metabolism; 1989 Jul; 38(7):649-54. PubMed ID: 2500578
[TBL] [Abstract][Full Text] [Related]
13. Effect of diabetes on in vivo metabolism of [35S]-labeled glomerular basement membrane.
Cohen MP; Surma ML
Diabetes; 1984 Jan; 33(1):8-12. PubMed ID: 6690347
[TBL] [Abstract][Full Text] [Related]
14. Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats.
Reddi AS; Ramamurthi R; Miller M; Dhuper S; Lasker N
Biochem Med Metab Biol; 1991 Feb; 45(1):119-31. PubMed ID: 2015105
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effect of aldose reductase inhibition on increased basement membrane collagen fluorescence in diabetic rats.
Cohen MP; Klepser H; Wu VY
Gen Pharmacol; 1991; 22(4):603-6. PubMed ID: 1936894
[TBL] [Abstract][Full Text] [Related]
16. Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.
van den Born J; van Kraats AA; Bakker MA; Assmann KJ; van den Heuvel LP; Veerkamp JH; Berden JH
Diabetologia; 1995 Feb; 38(2):161-72. PubMed ID: 7713310
[TBL] [Abstract][Full Text] [Related]
17. Modulatory effect of bitter gourd (Momordica charantia LINN.) on alterations in kidney heparan sulfate in streptozotocin-induced diabetic rats.
Kumar GS; Shetty AK; Salimath PV
J Ethnopharmacol; 2008 Jan; 115(2):276-83. PubMed ID: 18024034
[TBL] [Abstract][Full Text] [Related]
18. Aldose reductase, glomerular metabolism, and diabetic nephropathy.
Cohen MP
Metabolism; 1986 Apr; 35(4 Suppl 1):55-9. PubMed ID: 3007926
[TBL] [Abstract][Full Text] [Related]
19. Glomerular basement membrane thickening in streptozotocin diabetic rats despite treatment with an aldose reductase inhibitor.
Osterby R; Gundersen HJ
J Diabet Complications; 1989; 3(3):149-53. PubMed ID: 2528558
[TBL] [Abstract][Full Text] [Related]
20. Early increase of chondroitin sulfate glycosaminoglycan in the glomerular basement membrane of rats with diabetic glomerulopathy.
Karasawa R; Nishi S; Suzuki Y; Imai N; Arakawa M
Nephron; 1997; 76(1):62-71. PubMed ID: 9171302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
